Organigram Global Inc. generates annual revenues scaling significantly across multi-million-dollar brackets, reflecting its robust market position in the regulated cannabis sector. According to recent financial reports and trailing twelve-month operational summaries, the company reports annual revenues hovering around $259 million to $310 million CAD, driven by strong wholesale volume growth, successful new product innovations, expanding international medical export partnerships, and strategic acquisitions designed to capture broader market share across competitive global jurisdictions.